These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 27367745

  • 1. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
    Wilson ME, O'Halloran H, VanderVeen D, Roarty J, Plager DA, Markwardt K, Gedif K, Lambert SR.
    Eye (Lond); 2016 Sep; 30(9):1187-94. PubMed ID: 27367745
    [Abstract] [Full Text] [Related]

  • 2. A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.
    Donnenfeld ED, Holland EJ, Solomon KD, Fiore J, Gobbo A, Prince J, Sandoval HP, Shull ER, Perry HD.
    Am J Ophthalmol; 2011 Oct; 152(4):609-617.e1. PubMed ID: 21704965
    [Abstract] [Full Text] [Related]

  • 3. Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study.
    Sheppard JD, Toyos MM, Kempen JH, Kaur P, Foster CS.
    Invest Ophthalmol Vis Sci; 2014 May 06; 55(5):2993-3002. PubMed ID: 24677110
    [Abstract] [Full Text] [Related]

  • 4. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.
    Foster CS, Davanzo R, Flynn TE, McLeod K, Vogel R, Crockett RS.
    J Ocul Pharmacol Ther; 2010 Oct 06; 26(5):475-83. PubMed ID: 20809807
    [Abstract] [Full Text] [Related]

  • 5. Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension.
    Tijunelis MA, Person E, Niziol LM, Musch DC, Ernest P, McBain M, Mian SI.
    J Cataract Refract Surg; 2017 Feb 06; 43(2):223-227. PubMed ID: 28366370
    [Abstract] [Full Text] [Related]

  • 6. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
    Lane SS, Holland EJ.
    J Cataract Refract Surg; 2013 Feb 06; 39(2):168-73. PubMed ID: 23232255
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery.
    Abessi B, Brooksby L, Schultze RL.
    Eye Contact Lens; 2018 Nov 06; 44 Suppl 2():S37-S42. PubMed ID: 28628490
    [Abstract] [Full Text] [Related]

  • 9. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain.
    Korenfeld MS, Silverstein SM, Cooke DL, Vogel R, Crockett RS, Difluprednate Ophthalmic Emulsion 0.05% (Durezol) Study Group.
    J Cataract Refract Surg; 2009 Jan 06; 35(1):26-34. PubMed ID: 19101421
    [Abstract] [Full Text] [Related]

  • 10. Difluprednate versus Prednisolone Acetate after Cataract Surgery: a Systematic Review and Meta-Analysis.
    KhalafAllah MT, Basiony A, Salama A.
    BMJ Open; 2019 Nov 02; 9(11):e026752. PubMed ID: 31678934
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery.
    Yaylali V, Ozbay D, Tatlipinar S, Yildirim C, Ozden S.
    Int Ophthalmol; 2004 Jan 02; 25(1):65-8. PubMed ID: 15085979
    [Abstract] [Full Text] [Related]

  • 12. Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies.
    Sheppard JD, Foster CS, Toyos MM, Markwardt K, Da Vanzo R, Flynn TE, Kempen JH.
    Ocul Immunol Inflamm; 2019 Jan 02; 27(3):484-496. PubMed ID: 29260952
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN, Pendelton RA, Jenkins JE.
    J Cataract Refract Surg; 1999 May 02; 25(5):699-704. PubMed ID: 10330648
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and potential complications of difluprednate use for pediatric uveitis.
    Slabaugh MA, Herlihy E, Ongchin S, van Gelder RN.
    Am J Ophthalmol; 2012 May 02; 153(5):932-8. PubMed ID: 22265149
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
    Wilson ME, Lambert SR, Plager DA, VanderVeen D, Roarty J, O'Halloran H.
    Eye (Lond); 2017 Mar 02; 31(3):506-507. PubMed ID: 27813524
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C, Neubauer AS, Kampik A, Schönfeld CL.
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug 02; 243(8):768-73. PubMed ID: 15756571
    [Abstract] [Full Text] [Related]

  • 20. Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment of acute anterior uveitis.
    Hedayatfar A, Hashemi H, Asgari S, Chee SP.
    Cornea; 2014 Apr 02; 33(4):366-72. PubMed ID: 24351572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.